Trials / Completed
CompletedNCT02248844
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 667 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum Toxin Type A | Botulinum toxin Type A injected into crow's feet line areas per clinical practice. |
Timeline
- Start date
- 2014-09-26
- Primary completion
- 2017-08-14
- Completion
- 2017-08-14
- First posted
- 2014-09-25
- Last updated
- 2019-07-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02248844. Inclusion in this directory is not an endorsement.